Gender differences in adverse drug reactions: knowledge synthesis and exploration
<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a research archivist expert in dataset metadata. Answer the question truthfully.  <|eot_id|><|start_header_id|>user<|end_header_id|> Here is the Description of a dataset. Description:'* In the third study we assessed whether gender differences in reported ADRs for drugs commonly prescribed among patients with type 2 diabetes were consistent at different time periods of drug exposure after treatment initiation. We also explored the association between gender differences in reported ADRs and gender differences in the dose of the prescribed drug over time' . Please return only a json list of at most 3 Keywords corresponding to the Description:.<|eot_id|><|start_header_id|>assistant<|end_header_id|> {"Answer" : ["Adverse Drug Reaction","Database study","Diabetes","Drug dosing","Gender differences","General practice","Intensive Monitoring","oral blood glucose-lowering drugs","Pharmacodynamics","Pharmacokinetics","Pharmacovigilance","Post-marketing data","Pre-marketing data","Primary care","Regulatory science","Sex differences"]} <|eot_id|>
 Here is the Description of a dataset. Description:'* In the third study we assessed whether gender differences in reported ADRs for drugs commonly prescribed among patients with type 2 diabetes were consistent at different time periods of drug exposure after treatment initiation. We also explored the association between gender differences in reported ADRs and gender differences in the dose of the prescribed drug over time' . Please return only a json list of at most 3 Keywords corresponding to the Description:.
* In the third study we assessed whether gender differences in reported ADRs for drugs commonly prescribed among patients with type 2 diabetes were consistent at different time periods of drug exposure after treatment initiation. We also explored the association between gender differences in reported ADRs and gender differences in the dose of the prescribed drug over time
Adverse Drug Reaction; Database study; Diabetes; Drug dosing; Gender differences; General practice; Intensive Monitoring; oral blood glucose-lowering drugs; Pharmacodynamics; Pharmacokinetics; Pharmacovigilance; Post-marketing data; Pre-marketing data; Primary care; Regulatory science; Sex differences